Results 141 to 150 of about 575,684 (277)

Myocardial Bridging [PDF]

Circulation, 2006
Sebastiaan C.A.M. Bekkers, Tim Leiner
openaire   +1 more source

Current status and future perspectives of platelet function‐guided precision antiplatelet therapy for patients with cerebral infarction

Neuroprotection, EarlyView.
Antiplatelet agents target the cyclooxygenase‐1 (COX‐1)/thromboxane A2 (TXA2) and adenosine diphosphate (ADP)‐P2Y12 (cytochrome P450 2C19 [CYP2C19]‐metabolized) platelet activation pathways, resulting in either drug resistance or over‐inhibition. The individualized therapeutic window balances ischemic risk (triggered by high on‐treatment platelet ...
Guoliang Zhu, Xiaoling Chen, Xinyi Huang, Quandan Tan, Qing Cao, Yali Yang, Yapeng Lin, Jie Yang   +7 more
wiley   +1 more source

Evaluation and Treatment of Myocardial Bridging by Clinical Phenotype. [PDF]

J Soc Cardiovasc Angiogr Interv
Uretsky BF, Aleksandric SB, Vallurupalli S, Chaus A, Hakeem A, Blankenship JC, Birnbaum Y, Kern MJ.   +7 more
europepmc   +1 more source

Precision immunomodulation for pediatric hemophagocytic lymphohistiocytosis in intensive care

Pediatric Investigation, EarlyView.
This review presents a bedside framework for recognizing pediatric hemophagocytic lymphohistiocytosis and cytokine storm, stabilizing organ dysfunction, identifying the underlying phenotype, selecting targeted immunomodulation, considering extracorporeal adjuncts, and reassessing response within 24–72 h. ABSTRACT Hemophagocytic lymphohistiocytosis (HLH)
Weerapong Lilitwat, Prakreeti Bhandari
wiley   +1 more source

Exertional Syncope Caused by Hemodynamically Significant Myocardial Bridging With Coronary Vasospasm. [PDF]

JACC Case Rep
Toya T, Miyazaki Y, Sekine O, Aoyama M, Sumida N, Nishimura T, Katsuki T, Sakamoto M, Inagawa K.   +8 more
europepmc   +1 more source

Bortezomib‐based chemotherapy in Chinese pediatric patients with relapsed/refractory acute lymphoblastic leukemia: A single‐center retrospective study

Pediatric Investigation, EarlyView.
Bortezomib‐based chemotherapy achieved an 88.9% remission rate in Chinese pediatric patients with relapsed/refractory B‐cell acute lymphoblastic leukemia, enabling 62.5% of responders to bridge to transplantation, while T‐cell acute lymphoblastic leukemia showed no response.
Xingyu Zhao, Jian Wang, Liping Que, Dunhua Zhou, Jianpei Fang, Luhong Xu   +5 more
wiley   +1 more source

Functional myocardial bridging resulting in sub-endocardial anterior myocardial infarction

Hellenic Journal of Cardiology, 2023
Linda Kimani, Ragheb Traify, Adeel Shahzad, Matthias Schmitt, Ioannis Dimarakis   +4 more
doaj   +1 more source

Systemic Right Ventricle and Myocardial Bridging: Hemodynamics and Surgical Solutions in Adult Congenital Heart Disease. [PDF]

JACC Case Rep
de Almeida Neto ACE, Pereira Cavalcanti LR.   +1 more
europepmc   +1 more source

Symptomatic myocardial bridging or cardiac Whipple's Diseas

, 2003
This report concerns a patient with articular and cardiac manifestations of Whipple's disease. The disease was diagnosed only when gastrointestinal symptoms had appeared, because all cardiac symptoms were attributed exclusively to myocardial bridging ...
Pego Regina Célia, Silva Nuno C. Figueiredo, Cabral Virgínia L. Ribeiro, Knecht Daniella   +3 more
core  

Expert consensus on clinical trial design guidelines for FLASH radiotherapy

Precision Radiation Oncology, EarlyView.
• FLASH radiotherapy has emerged as a transformative technology due to the underlying FLASH effect. • As FLASH radiotherapy moves toward clinical application, establishing standardized trial design principles is critical. • This expert consensus provides a roadmap for rigorous clinical evaluation of FLASH radiotherapy, accelerating safe translation of ...
Hui Luo, Chen Cheng, Chengliang Yang, Bing Li, Jiandong Zhang, Jinbo Yue, Zhaoyang Lou, Hui Liu, Jing Cai, Hong Ge   +9 more
wiley   +1 more source